Bipartisan bill seeks to tighten the domestic pharma supply chain
Drug shortages have sparked hearings, questions over why the US doesn’t do more domestic manufacturing, and the various causes. Now, a new bipartisan Senate bill …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.